Validation lifecycle management — CSV without the consultancy tail.
V5 ships its own validation pack — URS, FRS, configuration spec, IQ/OQ/PQ scripts, traceability matrix — and re-issues it on every release. You don't re-validate from scratch, and you don't pay six figures to a consultancy to manage a binder.
What breaks without this.
Validation packs cost more than the software
Most QMS vendors charge separately for IQ/OQ/PQ deliverables and re-bill on every release. The validation tail eats the savings for years.
Traceability matrices are kept by hand
URS → FRS → test case → script → evidence — maintained in spreadsheets, broken on every change, redone before every inspection.
Periodic review is improvised
When was the last system review? Who signed it? What did it cover? If the answer takes more than a minute, you have a 483 risk.
Records-by-execution. Compliance, by design.
Validation pack ships with the platform
URS, FRS, configuration spec, IQ/OQ/PQ templates, traceability matrix — included, version-controlled, re-issued on every release.
Live traceability matrix
Requirements, specs, test cases, scripts, and signed evidence linked in the system. Change a requirement; affected tests are flagged automatically.
Regression pack on every release
Every V5 release ships with a regression test pack and a release-specific validation summary. Customers run a delta — not a full re-PQ.
Periodic review as scheduled work
Annual system review, account review, audit-trail review — all scheduled, signed, and tracked as first-class records.
What to look for when you're buying.
Validation lifecycle management is where most GxP IT spend is wasted: paper protocols, manual execution, six-figure consultancies per release.
Vendor-supplied URS/FRS/CS
What it tests: Does the platform vendor ship URS, FRS, and configuration spec?
Why it matters: Customer-authored URS for a configured product is duplicative effort with no compliance gain.
V5: V5 ships URS, FRS, configuration spec, and traceability matrix with the platform.
Automated IQ/OQ/PQ execution
What it tests: Are validation protocols executable in the system — with evidence captured automatically?
Why it matters: Manual protocol execution is the dominant cost driver.
V5: IQ/OQ/PQ scripts execute against the running system; results, screenshots, and signatures capture automatically.
Regression pack on every release
What it tests: Does the vendor re-issue a regression pack for every release?
Why it matters: Without a regression pack, customers re-validate ad hoc.
V5: Every minor release ships a regression pack; majors ship full PQ.
GAMP 5 category alignment
What it tests: Is the product classified per GAMP 5 — and validation effort scaled accordingly?
Why it matters: Validating a Category 4 product as Category 5 wastes six figures.
V5: V5 is GAMP Category 4 configured product; effort is scoped accordingly.
Risk-based validation effort
What it tests: Does the system support risk-based effort scaling per ICH Q9?
Why it matters: Validating every field at the same depth is wasteful.
V5: Risk classification drives validation depth; rationale captured per requirement.
Traceability matrix live
What it tests: Is the traceability matrix a live derivation — not a Word doc?
Why it matters: Stale traceability matrices are inspection liabilities.
V5: Traceability is derived live from URS → FRS → test scripts → evidence.
Change control linked to re-validation
What it tests: Does change control automatically scope the affected validation impact?
Why it matters: Manual change-impact assessment grows validation tails.
V5: Change records carry impact scope; affected scripts re-execute as part of release.
Audit-ready package on demand
What it tests: Can you hand the inspector URS/FRS/IQ/OQ/PQ/regression on demand?
Why it matters: Prep time is the tell of an incomplete validation lifecycle.
V5: On-demand package generation; the package is the live state of the system.
Spreadsheet vs legacy QMS vs V5.
VLM compared across three options.
| Capability | Spreadsheet | Legacy QMS | V5 Ultimate |
|---|---|---|---|
| Validation cost per major release | N/A | $200K-$500K consultancy | Included |
| Validation cost per minor release | N/A | $30K-$100K | Regression delta only |
| URS/FRS authorship | Customer | Customer | Vendor-supplied, customer-extended |
| IQ/OQ/PQ execution | Manual on paper | Manual in module | Automated with evidence capture |
| Traceability matrix | Stale Word doc | Maintained, often stale | Live derivation |
| Change control impact | Manual | Manual + lookup | Auto-scoped |
| Annex 11 + Part 11 dual coverage | Two sets | Two sets | One architecture |
| Inspection package time | Weeks | Days | On demand |
The clauses, verbatim — and how V5 answers each.
VLM-relevant clauses.
Validation of systems to ensure accuracy, reliability, consistent intended performance…
V5: Validation pack ships with the product and re-issues on every release; PQ evidence is regenerated against the new build.
Validation documentation and reports should cover the relevant steps of the lifecycle.
V5: Lifecycle artifacts (URS, FRS, CS, RA, RTM, IQ, OQ, PQ, regression) are shipped and updated together.
User Requirements Specifications should describe the required functions of the computerised system…
V5: URS shipped baseline; customer extends with site-specific GMP impact assessment.
A life cycle approach within an established Quality Management System.
V5: V5 operates the GAMP 5 lifecycle within the V5 QMS itself — the system validates the system.
Quality risk management should be integrated into existing operations…
V5: Risk-based effort scaling is built into the validation workflow; rationale captured per requirement.
An on-going programme of computerised system validation should exist that is appropriate to the level of risk.
V5: Continuous validation: regression on every minor, full PQ on every major, change-driven re-validation in between.
Step by step on the floor.
How a V5 release moves through validation lifecycle.
- 1Pre-release
Vendor ships artifacts
Each release ships updated URS, FRS, configuration spec, risk assessment, IQ/OQ/PQ scripts, traceability matrix, and regression pack.
- 2Change impact
Auto-scoped against config
Customer's configuration is compared against new release; impacted scripts are identified automatically.
- 3Execution
Scripts run against running system
IQ/OQ/PQ execute automated where possible; manual steps capture evidence inline.
- 4Evidence
Traceability live
URS → FRS → test → evidence resolves live; gaps surface immediately.
- 5Release sign-off
QA signs the package
QA signs the validation package; the system enters production state with byte-identical artifacts available to inspectors.
- 6Ongoing
Continuous re-validation
Change records carry scope; affected scripts re-execute as part of the next release; validation is not a project, it is a state.
The math, with the assumptions visible.
VLM ROI is dominated by the validation tail cost most pharma IT teams treat as fixed.
Validation cost per major release
Vendor ships the pack; customer extends only site-specific GMP impact.
Validation cost per minor release
Auto-scoped change impact drives the delta; full re-execution is rare.
Time to validate a release
Automated execution and live traceability eliminate the bottleneck.
Inspection prep on validation
The package is the live state.
VLM is the unloved category that often pays back V5 by itself for pharma IT teams running multi-release-per-year cadence.
What changed on the floor.
Setting
A specialty pharma running a legacy QMS validated by a five-figure-monthly consultancy.
Before
Annual validation spend was $640K. Each minor release added 6-10 weeks of validation tail; majors added 4-6 months. Inspection prep ran 6 weeks on validation alone.
After
Twelve months after V5 cutover for that subsystem: annual validation spend under $80K, releases validated inside 2 weeks, inspection prep on validation reduced to 1 day.
Proof points
- Validation pack included — no six-figure consultancy bill
- IQ/OQ/PQ regenerated on every release — no validation backlog
- Traceability matrix is live data — not a spreadsheet
- Periodic review scheduled, signed, evidenced — inspection-ready
Built to satisfy
- 21 CFR Part 11 (electronic records & signatures)
- EU GMP Annex 11 (computerised systems)
- GAMP 5 (validation lifecycle)
- ICH Q9 (quality risk management)
- PIC/S PI 011 (good practices for computerised systems)
Related on V5
Frequently asked questions
What is validation lifecycle management?+
It's the discipline of qualifying a computerised system through its entire life — requirements, design, installation, operational and performance qualification, change control, and periodic review — under GAMP 5 and 21 CFR Part 11 / Annex 11.
Does V5 include the validation pack?+
Yes. URS, FRS, configuration spec, IQ/OQ/PQ scripts, and the traceability matrix ship with the platform and are re-issued on every release. There is no separate purchase.
Do we re-validate on every V5 release?+
No. Each release ships with a regression test pack and a release-specific validation summary. Minor releases typically require a regression delta; major releases, a full PQ re-execution against the supplied scripts. The validation tail is days, not months.
Is V5 aligned with GAMP 5?+
Yes — risk-based, lifecycle-driven validation following the GAMP 5 V-model, with supplier-leveraged documentation reducing customer effort.
See V5 on your own line.
Free trial, no card. Live in 7 days with guided onboarding.